Handicare Group AB (publ) (“Handicare” or the “Company”), a leading global provider of mobility solutions in the Accessibility and Patient Handling markets, today announces the outcome of its Initial Public Offering (the “Offering”) and listing of shares on Nasdaq Stockholm. The Offering attracted very strong interest from both Swedish and International institutions as well as the general public in Sweden, board and employees of Handicare. The Offering was heavily over-subscribed.
The Offering in brief:
- As previously announced, the price per share in the Offering was SEK 50, corresponding to a total market value of the outstanding shares in Handicare upon completion of the Offering of SEK 2,947 million (approximately EUR 309 million).
- The number of shares in Handicare upon completion of the Offering will amount to 58,939,000 shares.
- Through the Offering, the cornerstone investors – The Fourth Swedish National Pension Fund, Danica Pension and Holta Life Sciences AS – will acquire 12.7% of the outstanding shares in the Company. Further, the Principal Shareholder has granted a right for Danica Pension to acquire from the Principal Shareholder up to an additional 0.8% of the total number of outstanding shares in the Company at a price that corresponds to the price in the Offering. The right might be exercised within 180 days from the completion of the Offering.
- In addition, Handicare’s Chairman of the Board Lars Marcher, Vice Chairman Johan Ek and board member Claes Magnus Åkesson have acquired in aggregate approximately 0.8% of the outstanding shares in the Company, corresponding to approximately SEK 25 million (approximately EUR 3 million), from the Principal Shareholder in connection with the Offering.
- Immediately following the completion of the Offering, assuming that the Over-allotment Option is exercised in full, Handicare’s largest shareholders will include the Principal Shareholder (62.9% of the total number of shares in Handicare upon completion of the Offering ), The Fourth Swedish National Pension Fund (5.1%), Danica Pension (4.19%) and Holta Life Sciences AS (3.4%).
Carnegie acted as Joint Global Coordinator and Joint Bookrunner in the IPO of Handicare.